“The opioid epidemic continues to take an emotional, physical and financial toll on Americans. The U.S. Food and Drug Administration is committed to taking every possible step to address the many facets of this complex public health crisis.
While we work to ensure appropriate and rational prescribing of opioids, we won’t lose sight of the needs of Americans living with serious chronic pain or coping with pain at the end of life. They too face significant challenges.
So, as we consider new policy steps to address the opioid addiction crisis, the FDA remains focused on striking the right balance between reducing the rate of new addiction by decreasing exposure to opioids and rationalizing prescribing, while still enabling appropriate access to those patients who have legitimate medical need for these medicines.”
Read more at: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm612779.htm
Source: FDA.Gov – July 9, 2018
See related article: FDA: Limiting Opioids Won’t Curb Crisis, Responsible Prescribing Will available at: https://www.thefix.com/fda-limiting-opioids-wont-curb-crisis-responsible-prescribing-will